Entrectinib

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 589 publications

Tissue-Agnostic Cancer Therapy Approvals.

Tissue-Agnostic Cancer Therapy Approvals.

Journal: Hematology/oncology clinics of North America

Published: September 02, 2026

Cancer Genomic Medicine in Neuro-Oncology Practice

Cancer Genomic Medicine in Neuro-Oncology Practice

Journal: No shinkei geka. Neurological surgery

Published: August 16, 2026

Novel inhibitors of BCRP found among drugs used in the treatment of cancer.

Novel inhibitors of BCRP found among drugs used in the treatment of cancer.

Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences

Published: July 06, 2026

ETV6-NTRK3 Fusion-Positive Late-Recurrent Parotid Carcinoma With Contralateral Axillary Metastasis and Early Response to Entrectinib: A Case Report.

ETV6-NTRK3 Fusion-Positive Late-Recurrent Parotid Carcinoma With Contralateral Axillary Metastasis and Early Response to Entrectinib: A Case Report.

Journal: Cureus

Published: June 27, 2026

Mechanistic PBPK Modeling of pH-Modifying Excipient Effects to Guide Formulation Design for Mitigating pH-Mediated DDIs.

Mechanistic PBPK Modeling of pH-Modifying Excipient Effects to Guide Formulation Design for Mitigating pH-Mediated DDIs.

Journal: Molecular pharmaceutics

Published: June 16, 2026

Differences Among Genomic Profiling Tests for Bone and Soft-Tissue Sarcomas in a Universal Health Insurance System.

Differences Among Genomic Profiling Tests for Bone and Soft-Tissue Sarcomas in a Universal Health Insurance System.

Journal: The Journal of bone and joint surgery. American volume

Published: May 27, 2026

Secretory Breast Carcinoma in A Six-Year-Old Girl: Case Report With Genetic Insights and Therapeutic Implications.

Secretory Breast Carcinoma in A Six-Year-Old Girl: Case Report With Genetic Insights and Therapeutic Implications.

Journal: Balkan journal of medical genetics : BJMG

Published: May 18, 2026

Comparative efficacy of taletrectinib versus first-generation TKIs in TKI-naïve ROS1+ non-small cell lung cancer: A matching-adjusted indirect comparison.

Comparative efficacy of taletrectinib versus first-generation TKIs in TKI-naïve ROS1+ non-small cell lung cancer: A matching-adjusted indirect comparison.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: May 15, 2026

Switching Tracks: Activity of Entrectinib After Progression While on Larotrectinib in Neurotrophin Receptor Tyrosine Kinase-Fused Pediatric High-Grade CNS Tumors.

Switching Tracks: Activity of Entrectinib After Progression While on Larotrectinib in Neurotrophin Receptor Tyrosine Kinase-Fused Pediatric High-Grade CNS Tumors.

Journal: JCO precision oncology

Published: May 14, 2026

TRK inhibitors in pediatric gliomas.

TRK inhibitors in pediatric gliomas.

Journal: Neuro-oncology advances

Published: April 30, 2026

Integrated machine learning and molecular dynamics-driven multi-target virtual screening of FDA-approved drugs for drug repurposing in breast cancer.

Integrated machine learning and molecular dynamics-driven multi-target virtual screening of FDA-approved drugs for drug repurposing in breast cancer.

Journal: In silico pharmacology

Published: April 25, 2026

Long-term disease control of GP2-NTRK1 fusion-positive pancreatic adenocarcinoma with liver metastases using sequential tyrosine receptor kinase inhibitors.

Long-term disease control of GP2-NTRK1 fusion-positive pancreatic adenocarcinoma with liver metastases using sequential tyrosine receptor kinase inhibitors.

Journal: Clinical journal of gastroenterology

Published: April 22, 2026

Showing 1-12 of 589

Last Updated: 09/26/2026